News


Syntame Biology

Pfizer China Launches Ecnoglutide – World’s First cAMP-Biased GLP-1 Drug

Learn More

Eli Lilly Announces Phase III Data for Retatrutide: 28.3% Weight Loss and Significant Systemic Anti-Inflammatory Effects, Ushering in the Triple-Target Era in GLP-1 Therapy

Learn More

First Oral Small-Molecule GLP-1 Drug Orforglipron (Foundayo™) Approved – A New Era in Obesity Treatment

Learn More

Total 3 < 1 > proceed page OK
SYNTAME

Manufacturers and suppliers of APIs and excipients and intermediates

We hope to cooperate with you!

If you have any questions or need a quote, please leave us a message and our experts will reply you within 24 hours.

SYNTAME BIOTECH
SUBMIT
%{tishi_zhanwei}%

Product Search

%{tishi_zhanwei}%